Neonious Biotech

Neonious Biotech

Created using Figma
Neonious Biotech is introducing the Neonious Token (MDSIM) which is intended to
incentivize large numbers of people to form the Neonious Network, a group of
computers which will perform the molecular dynamics simulations, by distributing
newly generated MDSIMs among these people based on the computing power they
provide to the cause. With the molecular dynamics simulations, Neonious Biotech
will power Alzheimer and dementia research.
Pre-ICO
25 mag 2021
31 ott 2021
100% completato
Fondi raccolti - nessun dato
Obbiettivo 250 000.00 USD
berretto 30 000 000.00 USD
past
  • 1 MDSIM
    =
    0.1 USD
Dettagli del token
telescrivente
MDSIM
Offerta totale
125000000
Distribuzione di token
80% Token Sale
11% Token Sale Marketing
6% Scientific Advisors
3% Neonious Employees
Valute accettate
ETH, USDC
Contributo minimo
250000
USD
Dettagli della Compagnia
Nome della società registrata
Neonious Biotech
Paese registrato
Germany
Struttura bonus
The price per token starts at 0.10 USD and will, as a minimum, increase by 0.01 USD after every 250,000 ordered tokens, making it worthwhile to buy early.
dettagli aggiuntivi
MVP / Prototipo
piattaforma
Ethereum
Paesi con restrizioni
Cuba, Iran, Lebanon, Libya, Syria, Sudan, Yemen
categorie
piattaforma

Di Neonious Biotech

We are pioneers of in silico prediction of drug safety and adverse reactions, limiting cost risks and reducing harm done to animals and humans.

To have the best tools for our drug analysis, we constantly optimize algorithms and pipelines and grow our distributed network which is a cost-efficient source for the needed computing power.

Our research is powered by the Neonious Network
and the Neonious Token (MDSIM).

Neonious is contracted to help to assess a drug for safety and adverse reactions.

Besides manual analysis, Neonious' research team utilizes computational pipelines

These pipelines queue simulations (docking + MD) to be run by the Neonious Network, paid with MDSIMs.

Sombody running the Neonious software, thus being part of the Neonious Network, runs the simulations.

This person is rewarded with easy transferable MDSIMs, which he or her can exchange for real money.

We believe it is beneficial to reduce risks by contract us to analyse your drug, preferable before starting preclinical research, latest before phase 2 of the human trials.

For lower cost, we can utilize the Neonious Network. Alternatively, the calculations can also be done on more private computing resources

Informazioni tecniche

https://github.com/neonious/WelcomeToCodeRepository

% name% Roadmap

  • 25/05/2021

  • Neonious Tokens can be ordered at the Neonious Biotech website. The earlier they are
    ordered, the cheaper the tokens are.
  • 01/07/2021

  • Extensively tested Neonious MD software available on GitHub (source code) and for
    download (Windows, macOS and Linux). May be used on testing network to generate new
    testing tokens.
  • 01/09/2021

  • Neonious MD software and mining contract passed security audit, results are published.
    Neonious Biotech starts the full ICO, preferably with a major exchange.
  • 31/10/2021

  • Neonious Token sale ends. Neonious Biotech will enable trading of Neonious Tokens for
    anyone on Uniswap by setting up an adequate liquidity pool.
  • Leggi di più
  • 01/11/2021

  • Neonious Biotech will start helping people set up their systems with the Neonious MD
    software to scale the Neonious Network.
  • 01/01/2022

  • Start of actual molecular dynamic simulations targeting dementia.
  • Early 2022

  • We plan to have reached an agreement for the Neonious Token to be listed at a major
    exchange.

Neonious Biotech Squadra

verificata 0%

Attenzione. C'è il rischio che i membri non verificati non siano effettivamente membri del team

Thomas Rogg
Chief Executive Officer & Head of Development Team
non verificato
Elena Elgina
Head of PR & Marketing
non verificato
Maria Cristina Fadgy...
Head of Scientific Affairs
non verificato
Martin Kämpf
Head of Digital Assets
non verificato

Neonious Biotech Ultime novità

  • Poiché potrebbero esserci differenze temporali negli aggiornamenti delle informazioni, è necessario verificare le informazioni accurate su ciascun progetto ICO attraverso il suo sito web ufficiale o altri canali di comunicazione.
  • Questa informazione non è un suggerimento o consiglio su come investire in finanziamenti ICO. Si prega di indagare approfonditamente le informazioni rilevanti da soli e decidere sulla partecipazione ICO.
  • Se pensi che ci siano problemi o problemi da correggere su questo contenuto, o se desideri inviare il tuo progetto ICO da elencare, per favore inviaci un'email.
Si prega di leggere la dichiarazione di non responsabilità e l'avviso di rischio. Mostra disclaimer e avviso di rischio.